326030.KS
SK Biopharmaceuticals Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 86,400.00
+0.12%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- KRW 595
- Revenue estimate
- KRW 250.9B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- KRW 582
- EPS estimate
- KRW 564
- Revenue actual
- KRW 247.4B
- Revenue estimate
- KRW 233.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +3.2%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026